MiP2014
MiP2014: Mitochondrial Physiology - a Point/Counterpoint Meeting
The Mitochondrial Physiology Society, Obergurgl, Tyrol, Austria. 2014-Sep-08 to 12
Programme structure
In each of the 12 sessions a point/counterpoint introduction will be given by invited keynote speakers to provide a balanced overview and promote discussions. Short oral presentations are selected from abstracts, including student presentations. Rapid platform statements will introduce posters which contribute to a specific session. Posters are up throughout the meeting, and poster discussions are integrated into the platform sessions.
A. Mitochondrial respiratory control
- A1. mtDNA, mt-phenotype and disease β is there biochemical and molecular-genetic evidence to explain observed associations?
- A2. Fission and fusion, mitochondrial structure and function - is there a tight connection?
- A3. Mitochondrial density and normalization of respiration β is there a general biochemical or molecular marker?
- A4. Biochemical reserve capacity, respiratory control ratios and coupling efficiency β are conventional concepts inconsistent?
B. Experimental protocols in mitochondrial biochemistry
- B1. Incubation media for mt-preparations and experimental temperature in functional studies of mammalian mitochondria β guided by concept or merely tradition?
- B2. Intracellular oxygen pressure versus oxygen regimes in studies of ROS production and respiration - are mitochondria sources or sinks of ROS?
- B3. Quantitative measurement of mt-membrane potential - potentiometric/fluorometric.
- B4. Instrumental platforms in mitochondrial physiology β industrial presentations.
C. Towards quality assurance
- C1. Do blood cells versus muscle biopsies provide valid models for diagnosis of mitochondrial pathologies?
- C2. Integrity of mitochondrial preparations β is a consensus possible on quality control criteria?
- C3. Availability and quality control of chemicals used in mitochondrial research β who controls?
- C4. Standards for the diagnosis of mitochondrial pathologies β a challenge for collaboration with mitochondrial organizations?
Particularly in view of Subtopic C, it may be attractive for mitochondrial organizations to send and support delegates. The conference will, therefore, provide a unique forum for international networking, and may inspire new national groups to be formed in contact with established mitochondrial organizations:
>> MitoGlobal_Organizations
International programme committee
The international programme committee will provide scientific input by active participation, nominate further invited speakers to ensure balanced point/counterpoint introductions, and select the abstracts as a basis for participation (restricted number of participants), for oral short presentations, and for flash presentations. Chair:
- Gnaiger Erich, Medical University Innsbruck, AT. - [email protected]
Members (confirmed):
- Ali Sameh S, Helmy Institute of Medical Sciences, Giza, Egypt
- Borutaite Vilma, Lithuanian University of Health Sciences Kaunas, LT
- Dela Flemming, University of Copenhagen, DK
- Duchen Michael R, University College London, UK
- ElmΓ©r Eskil, Lund University, SE
- Koopman Werner J, Radboud Univ Nijmegen Medical Centre, NL
- Neufer P Darrel, East Carolina University, Greenville, NC, US
- Ojuka Edward, University of Cape Town, South Africa
- Perry Christopher G, York University, Toronto, Canada
- Rossignol Rodrigue, UniversitΓ© Victor Segalen-Bordeaux, FR
- Vercesi Anibal E, State University of Campinas, Sao Paulo, Brazil
- Wei Yau-Huei, Mackay Medical College, New Taipei City, Taiwan
Members (invited):
- Chakrabarti Sasanka, Institute of Post-graduate Medical Education & Research, Kolkatta, India
- Chen Quan, Chinese Academy of Sciences, Nankai University, Beijing
- Haas Richard H, University of California San Diego, CA, USA
- Hickey Anthony J, University of Auckland, NZ
- Pecina Petr, Academy of Sciences of the Czech Republic, CZ
- Tanaka Masashi, Toyko Metropolitan Institute of Gerontology, JP
- Zorzano Antonio, Universitat de Barcelona, Spain